PTC THERAPEUTICS, INC. — Director's Dealing 2017

Jan 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2017-01-03

Reporting Person: ZELDIS JEROME B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-03	Stock Option (Right To Buy)	$11.23	A	12000	Acquired	2027-01-02	Common Stock (12000.0)	Direct

Footnotes

F1: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017.